UCLA Health Jonsson Comprehensive Cancer Center

June 22, 2022

Approximately 140 in 100,000 pregnant women receive a cancer diagnosis. Of these diagnoses, 0.1% are considered malignant tumors.

June 02, 2022

Updates to the NCCN guidelines for patients with resectable early-stage NSCLC now include neoadjuvant and adjuvant regimens with chemotherapy, immunotherapy, and targeted therapies, which promise to change biomarker testing practice.

May 24, 2022

Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, discusses how collaboration between an oncology unit and discharge lounge can improve discharge times for patients who have undergone stem cell transplantation.

April 30, 2022

Point-of-use shower filtration may be an effective strategy in reducing waterborne pathogens and protecting patients who underwent stem cell transplant from infection.

April 14, 2022

TTX-030 is the first fully human IgG4 antibody designed to target CD39, as well as the first CD39 inhibitor to undergo a phase 1 clinical trial.

April 13, 2022

Oncology nurses must assess the total pain of their patients by considering the physical, psychological, social, emotional, and spiritual elements.